UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.05 +0.05 (+0.06%) GOLD FUTURES
2,330.80 +19.80 (+0.86%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,115.76 -2,141.94 (-4.44%)
Enveric Biosciences, Inc. (ENVB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.86M |
| Enterprise value | -215.43k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.50 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.58 |
| 52-week change 3 | -46.29% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 6.9800 |
| 52-week low 3 | 0.6490 |
| 50-day moving average 3 | 1.0549 |
| 200-day moving average 3 | 1.6191 |
Share statistics
| Avg vol (3-month) 3 | 4.49M |
| Avg vol (10-day) 3 | 101.6k |
| Shares outstanding 5 | 7.29M |
| Implied shares outstanding 6 | 7.29M |
| Float 8 | 7.17M |
| % held by insiders 1 | 3.61% |
| % held by institutions 1 | 6.71% |
| Shares short (15 Apr 2024) 4 | 95.59k |
| Short ratio (15 Apr 2024) 4 | 0.03 |
| Short % of float (15 Apr 2024) 4 | 1.32% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.31% |
| Shares short (prior month 15 Mar 2024) 4 | 150.4k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 Nov 2019 |
| Ex-dividend date 4 | 23 Apr 2008 |
| Last split factor 2 | 1:50 |
| Last split date 3 | 15 Jul 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -86.20% |
| Return on equity (ttm) | -197.47% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -16.1M |
| Net income avi to common (ttm) | -17.46M |
| Diluted EPS (ttm) | -8.0900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.29M |
| Total cash per share (mrq) | 0.31 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.53 |
| Book value per share (mrq) | 0.71 |
Cash flow statement
| Operating cash flow (ttm) | -14.09M |
| Levered free cash flow (ttm) | -9.9M |
© 2024 Yahoo. All rights reserved.